期刊文献+
共找到191篇文章
< 1 2 10 >
每页显示 20 50 100
Parathyroid carcinoma located in the thyroid gland:A case report
1
作者 Shu-Yan Gui Chang-Ning Zhang +2 位作者 Li Ling Ruo-Xi Tang Jing Yang 《World Journal of Clinical Cases》 SCIE 2024年第18期3609-3614,共6页
BACKGROUND Parathyroid carcinoma(PC)is a difficult-to-diagnose rare disease with low incidence.Relatively accurate preoperative diagnosis is very important in choosing surgical methods and patient prognosis.CASE SUMMA... BACKGROUND Parathyroid carcinoma(PC)is a difficult-to-diagnose rare disease with low incidence.Relatively accurate preoperative diagnosis is very important in choosing surgical methods and patient prognosis.CASE SUMMARY This study reported the clinical diagnosis and treatment of a rare patient with PC located in the thyroid gland and provided a case reference for the diagnosis and treatment of PC.A case of a 64-year-old male patient who presented to our hospital with systemic muscle and joint pain and palpitations is outlined.Subsequently,the patient was admitted to the Department of Nephrology for the treatment of“multiple myeloma nephropathy pending investigation”.The patient was diagnosed with“primary hyperparathyroidism and hypercalcemic crisis”using thyroid color ultrasound.CONCLUSION The intraoperative frozen section report considered the parathyroid tumor.Surgical tumor resection was promptly performed,and the diagnosis of PC was confirmed. 展开更多
关键词 parathyroid carcinoma Surgical resection Fine needle aspiration Intraoperative frozen section Case report
下载PDF
Parathyroid carcinoma:Three case reports
2
作者 Ce Shi Ning Lu +2 位作者 Yan-Jie Yong Hai-Di Chu Ai-Jun Xia 《World Journal of Clinical Cases》 SCIE 2023年第25期5934-5940,共7页
BACKGROUND Parathyroid carcinoma(PC)is a rare,slow-growing malignant tumor and a rare cause of primary hyperfunctioning of the parathyroid,with a highly variable clinical course,depending on the aggressiveness of the ... BACKGROUND Parathyroid carcinoma(PC)is a rare,slow-growing malignant tumor and a rare cause of primary hyperfunctioning of the parathyroid,with a highly variable clinical course,depending on the aggressiveness of the individual tumor and the degree of hypercalcemia.CASE SUMMARY The aim of this report is to summarize the diagnosis and treatment of three cases of PC and to review and conclude aspects regarding the three collected cases with reference to other relevant cases to explore the value of ultrasound in the diagnosis of PC.All three patients had hypercalcemia,consisting of a high serum calcium level and a high level of parathyroid hormone that was>2-fold(even>30-fold)of the normal upper limit.The ultrasonographic findings of the parathyroid gland showed that the glands were all>30 mm,and the internal echo was uneven.All patients underwent surgery.PC in three cases was confirmed by routine histopathology and immunohistochemistry.CONCLUSION As clinical signs and laboratory results are nonspecific,it is difficult to diagnose PC preoperatively,so imaging examinations are often needed. 展开更多
关键词 parathyroid carcinoma parathyroid adenoma ULTRASOUND parathyroid hormone Primary parathyroid hyperfunction Case report
下载PDF
Parathyroid carcinoma in pregnancy
3
作者 Maja Baretic Hrvojka Tomic Brzac +1 位作者 Margareta Dobrenic Antonia Jakovcevic 《World Journal of Clinical Cases》 SCIE 2014年第5期151-156,共6页
A 24-year-old female patient with parathyroid carcinoma,the rarest endocrine malignancy,had two pregnancies.In the first pregnancy,she had severe nausea and fatigue.Hypercalcemia and hyperparathyroidism were diagnosed... A 24-year-old female patient with parathyroid carcinoma,the rarest endocrine malignancy,had two pregnancies.In the first pregnancy,she had severe nausea and fatigue.Hypercalcemia and hyperparathyroidism were diagnosed in the postpartum period.Hyperemesis gravidarum masked a diagnosis of hypercalcemia.Neck ultrasound and Tc-99 m sestamibi found an enlarged lower right parathyroid gland.The gland was surgically removed,and an initial pathology report described atypical adenoma.Shortly afterward,she became pregnant again.During the second pregnancy,her calcium level was frequently controlled but was always in the normal range.Normocalcemia is explained by the specific physiology of pregnancy accompanied by hemodilution,hypoalbuminemia and maternal hypercalciuria(mediated by increased glomerular filtration).During lactation,calcium levels rose,and a newneck ultrasound showed a solitary mass in the area of prior surgery and an enlarged pretracheal lymph node.Fine needle aspiration of the solitary mass and node showed parathyroid carcinoma cells.The tumor mass was resected en bloc with the contiguous tissues and surrounding lymph nodes(pathology report; parathyroid carcinoma with metastases).Over the next five years,four consecutive surgeries were performed to remove malignant parathyroid tissue,lymph nodes and local metastases.Following the surgical procedures,no hypocalcemia was observed.More serious hypercalcemia recurred; the calcium level was difficult to control with a combination of pamidronate,cinacalcet and loop diuretic.No elements of multiple endocrine neoplasia were present. 展开更多
关键词 parathyroid carcinoma HYPERCALCEMIA HYPERparathyroidISM PREGNANCY Hyperemesis gravidarum
下载PDF
Gonadotrophin-releasing hormone agonist-induced pituitary adenoma apoplexy and casual finding of a parathyroid carcinoma:A case report and review of literature
4
作者 Vanessa Trivino Olga Fidalgo +2 位作者 Antía Juane Jorge Pombo Fernando Cordido 《World Journal of Clinical Cases》 SCIE 2019年第20期3259-3265,共7页
BACKGROUND Pituitary apoplexy represents one of the most serious,life threatening endocrine emergencies that requires immediate management.Gonadotropin-releasing hormone agonist(GnRHa)can induce pituitary apoplexy in ... BACKGROUND Pituitary apoplexy represents one of the most serious,life threatening endocrine emergencies that requires immediate management.Gonadotropin-releasing hormone agonist(GnRHa)can induce pituitary apoplexy in those patients who have insidious pituitary adenoma coincidentally.CASE SUMMARY A 46-year-old woman,with a history of hypertension and menorrhagia was transferred to our hospital from a secondary care hospital after complaints of headache and vomiting,with loss of consciousness 5 min after an injection of GnRHa.The drug was prescribed by her gynecologist due to the presence of uterine myomas.The clinical neurological examination revealed right cranial nerve III palsy,ptosis and movement limitation of the right eye.Our first clinical consideration was a pituitary apoplexy.Blood hormonal analysis revealed mild hyperprolactinemia and high follicle stimulating hormone level;PTH and calcium was high with glomerular filtration rate mildly to moderately decrease.A computed tomography scan,revealed an enlarged pituitary gland(3.5 cm)impinging upon the optic chiasm with bone involvement of the sella.Following contrast media administration,the lesion showed homogeneous enhancement with high-density focus that suggests hemorrhagic infarction of the tumor.Transsphenoidal endoscopic surgery was perfomed and adenomatous tissue was removed.Immunohistochemistry was positive for luteinizing hormone(LH)and follicular-stimulating hormone(FSH).A solid hypoechoic nodule(14 mm x 13 mm x 16 mm)was found in the caudal portion of the right thyroid lobe after a parathyroid ultrasound.A genetic test of Multiple Endocrine Neoplasia type 1(MEN1)was negative.A right lower parathyroidectomy was performed and the pathologic study showed the presence of an encapsulated parathyroid carcinoma of 1.5 cm.A MEN type 4 genetic test was performed result was negative.CONCLUSION This case demonstrates an uncommon complication of GnRH agonist therapy in the setting of a pituitary macroadenoma and the casual finding of parathyroid carcinoma.It also highlights the importance of suspecting the presence of a multiple endocrine neoplasia syndrome and to carry out relevant genetic studies. 展开更多
关键词 Pituitary apoplexy Pituitary adenoma Primary hyperparathyroidism MEN type 1 MEN type 4 parathyroid carcinoma Case report
下载PDF
Lessons learned from a young man with recurrent metastasis parathyroid carcinoma with failed combination treatment
5
作者 Yan-Jun Su Shao-Hao Cheng +7 位作者 Xi-Xiang Gong Wei Zhao Gao-Hong Zhu Bo He Yu-Shan Xu Hua Zhou JunQian Ruo-Chuan Cheng 《TMR Cancer》 2021年第2期1-11,共11页
Parathyroid carcinoma is an extremely rare malignant tumor,composed primarily of vacuolated principal cells,but may also be composed of eosinophils.The exact etiology and pathogenesis of parathyroid carcinoma is unkno... Parathyroid carcinoma is an extremely rare malignant tumor,composed primarily of vacuolated principal cells,but may also be composed of eosinophils.The exact etiology and pathogenesis of parathyroid carcinoma is unknown,and head and neck radiation exposure,chronic stimulation from renal failure,and familial syndromes can lead to the development of parathyroid carcinoma.Most parathyroid carcinoma is difficult to distinguish from benign HPT and is often diagnosed only when there is a recurrence of hypercalcemia several years later,which can manifest as weight loss,extreme fatigue,anorexia,and muscle atrophy.At present,surgical resection remains the primary treatment.In this case,the patient underwent initial surgery for primary hyperparathyroidism and was subsequently diagnosed with parathyroid carcinoma.During the 8 years of follow-up,the patient underwent 7 surgeries in combination with radiation therapy,chemotherapy and targeted medications.Although the neck tumor was cured,the patient died of complications related to hypercalcemia.We will review the literature on the combination of surgery,radiotherapy,chemotherapy,and targeted drug therapy in order to improve the diagnosis and treatment of parathyroid carcinoma. 展开更多
关键词 parathyroid carcinoma HYPERCALCEMIA Surgery RADIOTHERAPY CHEMOTHERAPY
下载PDF
Parathyroid carcinoma initiated by hypercalcemic crisis
6
作者 LIU Jian-ping WANG Xian-ling SHI Jun DOU Jing-tao BA Jian-ming LU Zhao-hui YANG Li-juan LIU Ju-ming LI Chun-lin MU Yi-ming 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第4期792-794,共3页
Parathyroid carcinoma (PC) is a rare neoplasm that accounts for 0. 1%-5% of primary hyperparathyroidism cases. Hyperparathyroidism-induced hypercalcemic crisis (HHC) is sometimes due to a single PC.1 However,
关键词 parathyroid carcinoma HYPERparathyroidISM hypercalcemie crisis en bloc resection
原文传递
Effect of parathyroid hormone on apoptosis of human medullary thyroid carcinoma cells
7
作者 Xiaofeng Hou Qinjiang Liu Youxin Tian 《Oncology and Translational Medicine》 2017年第6期241-244,共4页
Objective The aim of the study was to investigate the effect of parathyroid hormone(PTH) on the apoptosis of human medullary thyroid carcinoma(MTC) cells.Methods In vitro cultured medullary thyroid carcinoma cell line... Objective The aim of the study was to investigate the effect of parathyroid hormone(PTH) on the apoptosis of human medullary thyroid carcinoma(MTC) cells.Methods In vitro cultured medullary thyroid carcinoma cell lines were treated with parathyroid hormone and parathyroid hormone receptor-monoclonal antibody,and the apoptosis of cells was detected by flow cytometry.Results The cell morphology changed significantly after treatment based on the observation using the inverted phase-contrast microscope.Various concentrations of parathyroid hormone and parathyroid hormone receptor-monoclonal antibody effectively induced apoptosis in a time-and concentrationdependent manner.When the concentration of parathyroid hormone was 2.0 μmol/L and that of parathyroid hormone receptor-monoclonal antibody was 1.0 μmol/L,the apoptotic rate was 13.24% and 20.78%,respectively,representing a statistically significant difference from that of the control cells(P < 0.05).Conclusion PTH plays a role in inducing apoptosis of human MTC cells. 展开更多
关键词 parathyroid HORMONE (PTH) MEDULLARY THYROID carcinoma (MTC) cell APOPTOSIS
下载PDF
甲状旁腺癌与甲状旁腺腺瘤的超声鉴别诊断
8
作者 张晓鸽 樊玉霞 滑少华 《郑州大学学报(医学版)》 CAS 北大核心 2024年第1期130-133,共4页
目的:分析超声鉴别甲状旁腺癌和甲状旁腺腺瘤的价值。方法:回顾性分析2016年1月至2021年12月于郑州大学第一附属医院经手术切除明确诊断的甲状旁腺肿瘤患者的临床资料,其中甲状旁腺癌21例,腺瘤27例。比较两组的超声征象。结果:甲状旁腺... 目的:分析超声鉴别甲状旁腺癌和甲状旁腺腺瘤的价值。方法:回顾性分析2016年1月至2021年12月于郑州大学第一附属医院经手术切除明确诊断的甲状旁腺肿瘤患者的临床资料,其中甲状旁腺癌21例,腺瘤27例。比较两组的超声征象。结果:甲状旁腺癌组男性患者比例高于腺瘤组,右下病变占比低于腺瘤组,超声回声为囊实性、血流为3级、有钙化的患者比例高于腺瘤组(P<0.05)。超声对甲状旁腺癌和腺瘤鉴别诊断的敏感度为85.71%,特异度为74.07%,约登指数为0.60。结论:超声检查对甲状旁腺癌及腺瘤具有一定的鉴别诊断价值。 展开更多
关键词 甲状旁腺癌 甲状旁腺腺瘤 超声检查 鉴别诊断
下载PDF
甲状旁腺术中识别技术及临床应用和研究现况 被引量:1
9
作者 贺晨宇 姜可伟 《西安交通大学学报(医学版)》 CSCD 北大核心 2024年第1期49-54,共6页
甲状旁腺在机体钙磷代谢中有重要作用,颈部手术中完整保留甲状旁腺对避免术后甲状旁腺功能减退和术后低钙血症至关重要。目前大多数甲状腺手术中仍依赖传统肉眼识别方式或通过术中冰冻辨认甲状旁腺,前者依赖于术者经验,后者所消耗的时... 甲状旁腺在机体钙磷代谢中有重要作用,颈部手术中完整保留甲状旁腺对避免术后甲状旁腺功能减退和术后低钙血症至关重要。目前大多数甲状腺手术中仍依赖传统肉眼识别方式或通过术中冰冻辨认甲状旁腺,前者依赖于术者经验,后者所消耗的时间和费用较高。近年,国内外学者对术中有助于识别甲状旁腺的染色技术和基于荧光的成像技术进行了相关研究,如亚甲蓝、纳米炭、近红外自体荧光、吲哚菁绿血管造影技术、激光散斑对比成像等,均可显著提高对甲状旁腺的识别与保护。本文将对甲状旁腺术中识别技术的临床研究进展情况作一综述。 展开更多
关键词 甲状腺癌根治术 甲状旁腺保护 术中识别
下载PDF
多模态成像诊断^(99)Tc^(m)-MIBI显像阴性甲状旁腺癌1例
10
作者 韩云峰 彭丹 《标记免疫分析与临床》 CAS 2024年第4期776-780,共5页
甲状旁腺癌(parathyroid carcinoma,PC)是一种罕见的内分泌肿瘤,相比良性原发性甲状旁腺功能亢进症(primary hyperparathyroidism,PHPT),PC常伴有严重的、难治性高钙血症,更容易诱发高钙危象。PC的预后和总生存期取决于原发肿瘤的大小... 甲状旁腺癌(parathyroid carcinoma,PC)是一种罕见的内分泌肿瘤,相比良性原发性甲状旁腺功能亢进症(primary hyperparathyroidism,PHPT),PC常伴有严重的、难治性高钙血症,更容易诱发高钙危象。PC的预后和总生存期取决于原发肿瘤的大小、肿瘤分期、诊断时的侵袭情况以及早期手术切除所有癌组织的可能性,因而准确的术前影像学评估对于PC治疗至关重要。本文报告了多模态成像协助诊断^(99)Tc^(m)-MIBI显像阴性的PC患者1例,辅助了临床诊疗方案制定。此案例说明,多模态影像可以在PC定性、定位、定量、定期上优势互补,有利于PC的术前诊断及预后评价,有助于临床决策。 展开更多
关键词 甲状旁腺癌 ^(99)Tc^(m)-MIBI 多模态成像
下载PDF
示踪剂盐酸米托蒽醌在甲状腺癌根治术中的应用
11
作者 刘晓明 武宜雷 刘学键 《局解手术学杂志》 2024年第1期66-68,共3页
目的研究示踪剂盐酸米托蒽醌在甲状腺癌根治术中对淋巴结染色率、淋巴结示踪率及甲状旁腺误切率的影响。方法选取2022年2月至8月于我院行甲状腺癌根治术的106例患者,随机分为对照组和观察组,每组53例。记录患者淋巴结染色率、示踪持续... 目的研究示踪剂盐酸米托蒽醌在甲状腺癌根治术中对淋巴结染色率、淋巴结示踪率及甲状旁腺误切率的影响。方法选取2022年2月至8月于我院行甲状腺癌根治术的106例患者,随机分为对照组和观察组,每组53例。记录患者淋巴结染色率、示踪持续成功率。比较2组患者淋巴结清除数目、甲状旁腺误切率,及2组患者术前及术后第1天、第3天血钙和甲状旁腺激素(PTH)。结果观察组患者淋巴结染色率为90.1%,示踪持续成功率为100%。2组患者淋巴结清除数目,甲状旁腺误切率,术后第1天、第3天血钙和PTH比较差异均有统计学意义(P<0.05)。结论示踪剂盐酸米托蒽醌具有良好的安全性和淋巴结示踪性,能降低甲状旁腺误切率,值得临床推广应用。 展开更多
关键词 示踪剂 盐酸米托蒽醌 甲状腺癌 淋巴结 甲状旁腺
下载PDF
术前超声引导下注射纳米炭在cN 0期甲状腺乳头状癌根治手术中的应用分析 被引量:1
12
作者 赵鹏 包钰铃 +2 位作者 罗永标 梁全琨 许坚 《中国临床新医学》 2023年第8期784-788,共5页
目的观察术前应用纳米炭混悬注射液在cN 0甲状腺乳头状癌患者根治性手术中对中央区淋巴结清扫的效果的影响及评估其在甲状旁腺功能保护中的作用。方法选取广西医科大学附属肿瘤医院头颈外科2021年9月至2023年6月收治的cN 0期甲状腺乳头... 目的观察术前应用纳米炭混悬注射液在cN 0甲状腺乳头状癌患者根治性手术中对中央区淋巴结清扫的效果的影响及评估其在甲状旁腺功能保护中的作用。方法选取广西医科大学附属肿瘤医院头颈外科2021年9月至2023年6月收治的cN 0期甲状腺乳头状癌患者104例,随机分为观察组和对照组各52例,观察组于术前1 d在原发肿瘤周围注射纳米炭混悬注射液0.2 ml,对照组不注射。两组患者均行单侧甲状腺切除术+中央区淋巴结清扫术,依据手术入路的不同,进一步将观察组分为开放观察组(26例)、腔镜观察组(26例),同样将对照组分为开放对照组(26例)、腔镜对照组(26例)。比较各组的手术时间、术中出血量、住院时间、检出淋巴结数量、阳性淋巴结数量及甲状旁腺误切率等。结果104例甲状腺切除患者术后发生甲状旁腺误切14例(13.46%),观察组甲状旁腺误切率显著低于对照组(P<0.05)。观察组检出淋巴结数量及阳性淋巴结数量均显著多于对照组(P<0.05)。观察组与对照组患者手术时间、术中出血量、住院时间比较差异无统计学意义(P>0.05)。亚组分析中,腔镜观察组较腔镜对照组甲状旁腺误切率低,差异有统计学意义(P<0.05)。结论术前应用纳米炭混悬注射液在cN 0期甲状腺乳头状癌根治性手术中可提高淋巴结检出数量,降低甲状旁腺误切率,在经腋窝腔镜甲状腺癌根治手术中对甲状旁腺功能保护作用显著。 展开更多
关键词 纳米炭 甲状腺乳头状癌 甲状旁腺 手术方式 功能保护
下载PDF
腔镜甲状腺癌根治术联合甲状旁腺自体移植术对甲状旁腺功能恢复的影响 被引量:6
13
作者 张琪 王泽升 +3 位作者 高金伟 章婧 张宇鹏 屈坤鹏 《解放军医学杂志》 CAS CSCD 北大核心 2023年第4期437-444,共8页
目的探讨腔镜甲状腺癌根治术联合甲状旁腺自体移植术对术后甲状旁腺功能恢复的影响。方法回顾性纳入2019年1月-2021年4月甘肃省人民医院普外科收治的323例行腔镜甲状腺癌根治术患者的临床资料,根据术中是否行选择性甲状旁腺自体移植术... 目的探讨腔镜甲状腺癌根治术联合甲状旁腺自体移植术对术后甲状旁腺功能恢复的影响。方法回顾性纳入2019年1月-2021年4月甘肃省人民医院普外科收治的323例行腔镜甲状腺癌根治术患者的临床资料,根据术中是否行选择性甲状旁腺自体移植术分为移植组(n=171)与非移植组(n=152)。记录两组患者术前及术后1 d、1周、1个月、3个月、6个月、12个月的体循环甲状旁腺激素(PTH)、Ca2+浓度及甲状旁腺功能减退发生情况,收集移植患者双臂肘窝静脉PTH浓度。采用logistic回归分析甲状腺术后甲状旁腺功能减退的危险因素。结果移植组暂时性甲状旁腺功能减退发生率高于非移植组(33.33%vs.23.03%),永久性甲状旁腺功能减退率低于非移植组(0.58%vs.5.26%),差异有统计学意义(P=0.007)。移植组术后1周至术后12个月的PTH浓度均高于非移植组,差异有统计学意义(P<0.001)。移植患者术后1周至术后12个月移植侧肘窝静脉PTH浓度明显高于非移植侧,差异有统计学意义(P<0.001)。术后12个月,移植组甲状旁腺PTH分泌功能恢复至术前的85.42%,非移植组恢复至术前的67.60%。单因素logistic回归分析显示,移植(OR=1.671,95%CI 1.020~2.738,P=0.041)和桥本甲状腺炎(OR=1.925,95%CI 1.138~3.259,P=0.015)是甲状腺术后暂时性甲状旁腺功能减退的危险因素,移植(OR=0.106,95%CI 0.013~0.857,P=0.035)是永久性甲状旁腺功能减退的保护因素。多因素logistic回归分析显示,移植(OR=1.736,95%CI 1.044~2.887,P=0.034)和桥本甲状腺炎(OR=1.903,95%CI1.111~3.258,P=0.019)是暂时性甲状旁腺功能减退的危险因素,移植(OR=0.101,95%CI0.012~0.839,P=0.034)是永久性甲状旁腺功能减退的保护因素。结论在腔镜甲状腺癌根治术中,甲状旁腺自体移植是预防永久性甲状旁腺功能减退的有效策略,但同时可导致术后短期内甲状旁腺功能减退;尽可能在原位保留上极甲状旁腺的基础上,选择性移植术中损伤或血供不良的下极甲状旁腺,更有利于术后甲状旁腺功能的恢复。 展开更多
关键词 腔镜甲状腺癌根治术 选择性甲状旁腺自体移植术 暂时性甲状旁腺功能减退 永久性甲状旁腺功能减退 中央区淋巴结清扫
下载PDF
纳米碳在甲状腺乳头状癌术中的应用进展 被引量:2
14
作者 吴天琦 张静 《实用医学杂志》 CAS 北大核心 2023年第8期1063-1066,共4页
手术切除仍然是甲状腺乳头状癌目前最有效的治疗方式,制定最优的淋巴结清扫范围以及降低手术并发症的发生率是至关重要的。纳米碳作为新一代显影剂在甲状腺乳头状癌术中保护甲状旁腺、示踪淋巴结方面发挥了重要作用,近年来已有较多的研... 手术切除仍然是甲状腺乳头状癌目前最有效的治疗方式,制定最优的淋巴结清扫范围以及降低手术并发症的发生率是至关重要的。纳米碳作为新一代显影剂在甲状腺乳头状癌术中保护甲状旁腺、示踪淋巴结方面发挥了重要作用,近年来已有较多的研究报道,但应用价值尚未得到明确肯定。本文对纳米碳在甲状腺乳头状癌术中的应用进展作一综述,为优化手术治疗策略提供进一步参考。 展开更多
关键词 甲状腺乳头状癌 纳米碳 甲状旁腺 淋巴结清扫
下载PDF
甲状腺乳头状癌甲状腺全切除术后甲状旁腺功能减退的影响因素及恢复时间分析 被引量:2
15
作者 林贝 周天晗 +5 位作者 周力 张煜 时晶晶 潘钢 彭友 罗定存 《浙江医学》 CAS 2023年第10期1030-1035,共6页
目的探讨甲状腺乳头状癌(PTC)甲状腺全切除术后甲状旁腺功能减退的影响因素及恢复时间。方法收集2016年1月至2019年12月浙江大学医学院附属杭州市第一人民医院肿瘤外科收治的PTC行甲状腺全切除术患者541例,均检测术前及术后第1天血清甲... 目的探讨甲状腺乳头状癌(PTC)甲状腺全切除术后甲状旁腺功能减退的影响因素及恢复时间。方法收集2016年1月至2019年12月浙江大学医学院附属杭州市第一人民医院肿瘤外科收治的PTC行甲状腺全切除术患者541例,均检测术前及术后第1天血清甲状旁腺激素(PTH)。分析术后第1天PTH水平降低的影响因素,采用ROC曲线评估术后第1天PTH水平对术后PTH恢复时间的预测效能。采用Kaplan-Meier曲线分析术后不同时间点的PTH恢复率。结果541例PTC患者中,术后1个月内PTH恢复正常459例,术后1~<2个月恢复正常49例,术后2~6个月恢复正常23例,超过半年未恢复正常10例。单因素分析结果显示,术前低PTH水平、双侧中央区淋巴结清扫、中央区淋巴结清扫数量增多均是术后第1天PTH降低的危险因素(均P<0.05);多因素logistic回归分析结果显示,术后第1天PTH水平是术后发生甲状旁腺功能减退的独立危险因素(P<0.05)。术后第1天PTH水平预测术后1、2个月PTH恢复及永久性甲状旁腺功能减退的AUC分别为0.741、0.777、0.850,对应的PTH截断值为13、7、5 pg/ml。Kaplan-Meier曲线分析结果显示,术后1个月PTH水平恢复率已达84.84%,以后仍逐渐上升。结论行甲状腺全切除术后甲状旁腺功能恢复时间与中央区淋巴结清扫数量有关,PTC患者术后第1天PTH水平可预测术后甲状旁腺功能恢复情况。 展开更多
关键词 甲状腺乳头状癌 甲状腺全切除术 甲状旁腺激素 甲状旁腺功能减退 恢复时间
下载PDF
甲状腺乳头状癌术后甲状旁腺功能减退症影响因素的临床分析 被引量:1
16
作者 麻通通 柴芳 《中国现代药物应用》 2023年第1期31-34,共4页
目的探讨甲状腺乳头状癌(PTC)术后甲状旁腺功能减退症(HPT)的相关因素。方法 回顾性分析200例PTC患者的临床资料,所有患者均行甲状腺全/近全切除和中央区淋巴结清扫治疗。依据术后甲状旁腺功能减退情况分为实验组(甲状旁腺功能减退, 72... 目的探讨甲状腺乳头状癌(PTC)术后甲状旁腺功能减退症(HPT)的相关因素。方法 回顾性分析200例PTC患者的临床资料,所有患者均行甲状腺全/近全切除和中央区淋巴结清扫治疗。依据术后甲状旁腺功能减退情况分为实验组(甲状旁腺功能减退, 72例)和对照组(甲状旁腺功能正常, 128例)。分析PTC术后HPT的影响因素及永久性和暂时性HPT的影响因素。结果 200例患者经甲状旁腺激素(PTH)血钙水平检测,共72例患者发生HPT,发生率为36.0%,其中5例为永久性HPT,67例为暂时性HPT。两组患者的年龄、手术范围、有无被膜侵犯、有无自体移植、Ⅵ区淋巴结双侧清扫比较差异有统计学意义(P<0.05)。多因素Logistic回归分析显示,手术范围、被膜侵犯、Ⅵ区淋巴结双侧清扫是术后HPT的独立危险因素(P<0.05)。永久性和暂时性HPT患者的Ⅵ区淋巴结清扫与手术范围的比较差异有统计学意义(P<0.05)。结论 HPT是甲状腺手术常见的术后并发症,其中被膜侵犯、手术范围、Ⅵ区淋巴结清扫是PTC术后HPT独立的危险因素。 展开更多
关键词 甲状腺乳头状癌 甲状旁腺功能减退症 血钙水平 甲状旁腺激素 影响因素
下载PDF
经胸-乳入路腔镜甲状腺癌根治术在早期甲状腺乳头状癌治疗中效果及患者应激指标、甲状腺功能和甲状旁腺功能观察
17
作者 丘志华 《外科研究与新技术》 2023年第4期255-257,共3页
目的探析在早期甲状腺乳头状癌中采用经胸-乳入路腔镜甲状腺癌根治术(ERT)的效果及对患者应激指标、甲状腺功能和甲状旁腺功能的影响。方法选取2020年1月—2023年1月诊治的62例早期甲状腺乳头状癌患者为研究对象,根据随机数字表法分为... 目的探析在早期甲状腺乳头状癌中采用经胸-乳入路腔镜甲状腺癌根治术(ERT)的效果及对患者应激指标、甲状腺功能和甲状旁腺功能的影响。方法选取2020年1月—2023年1月诊治的62例早期甲状腺乳头状癌患者为研究对象,根据随机数字表法分为对照组和观察组,每组各31例。对照组常规手术治疗,观察组经胸-乳入路ERT治疗。比较两组甲状腺功能、甲状旁腺功能[促甲状腺激素(TSH)、甲状腺激素(T_(4))、三碘甲状腺原氨酸(T_(3))、甲状旁腺素(PTH)]及应激指标[皮质醇(Cor)、超氧化物歧化酶(SOD)、去甲肾上腺素(NE)]水平。结果术后,观察组T_(3)、T_(4)、PTH、SOD水平高于对照组(P>0.05);观察组Cor、NE、TSH水平低于对照组(P<0.05)。结论在早期甲状腺乳头状癌中采用经胸-乳入路ERT治疗,可减轻患者应激反应,维持甲状腺及甲状旁腺功能。 展开更多
关键词 经胸-乳入路腔镜甲状腺癌根治术 甲状腺乳头状癌 应激指标 甲状腺功能 甲状旁腺功能
下载PDF
联合介入治疗功能性甲状旁腺癌骨转移及血钙危象一例 被引量:3
18
作者 田庆华 吴春根 +2 位作者 顾一峰 刘芳 程永德 《介入放射学杂志》 CSCD 北大核心 2013年第2期174-176,共3页
甲状旁腺癌(parathyroid carcinoma,PTC)发病率极低,而甲状旁腺癌发生骨转移并引起甲状旁腺功能亢进症状在临床上更为罕见.现将我科近来收治的1例病例报道如下。
关键词 甲状旁腺癌 射频消融术 经皮椎体成形术 骨转移
下载PDF
无症状原发性甲状旁腺功能亢进症患者的临床特点 被引量:4
19
作者 姚晓爱 姜涛 +1 位作者 魏伯俊 昌红 《中南大学学报(医学版)》 CAS CSCD 北大核心 2021年第4期368-372,共5页
目的:中国无症状原发性甲状旁腺功能亢进症(primary hyperparathyroidism,PHPT)的患病率低于欧美国家且研究较少。本研究旨在探讨无症状PHPT患者的临床特点。方法:回顾性分析150例行手术治疗并经病理检查证实的PHPT患者的临床资料。将... 目的:中国无症状原发性甲状旁腺功能亢进症(primary hyperparathyroidism,PHPT)的患病率低于欧美国家且研究较少。本研究旨在探讨无症状PHPT患者的临床特点。方法:回顾性分析150例行手术治疗并经病理检查证实的PHPT患者的临床资料。将患者分为有症状组(n=124)和无症状组(n=26)。结果:无症状PHPT组的腺瘤发生率高于腺癌(P=0.073);无症状PHPT组首诊原因为经常规生化指标检测发现高钙血症的比例高于有症状PHPT组(76.92%vs 25.81%,P<0.001)。与有症状PHPT组比较,无症状PHPT组病程明显较短(中位数12个月vs 24个月,P=0.004),血钙、血清校正钙及甲状旁腺激素明显较低(分别P=0.003、P=0.006及P=0.042),病变直径明显较短(P=0.028),1,25-二羟维生素D_(3)水平明显较高(P<0.001),L_(2~4)和股骨颈的骨密度明显较高(均P<0.001)。结论:无症状的PHPT患者仅占少数,与有症状的PHPT患者比较,无症状PHPT患者的首诊原因主要为高钙血症,其病程短,病变直径小,血钙和甲状旁腺激素水平低,维生素D和腰椎及股骨颈的骨密度较高,病理类型均为良性且腺瘤的比例较高。 展开更多
关键词 无症状原发性甲状旁腺功能亢进症 甲状旁腺癌 甲状旁腺腺瘤 甲状旁腺增生 临床特点
下载PDF
纳米碳在甲状腺癌手术中保护甲状旁腺的作用 被引量:11
20
作者 徐进 许维雪 +3 位作者 王海南 张伟明 梁杰佳 李鹤 《实用药物与临床》 CAS 2016年第4期471-474,共4页
目的探讨纳米碳在甲状腺癌手术中对甲状旁腺的保护作用。方法回顾性分析2014年1月至2015年1月我院收治的67例甲状腺癌患者的临床资料,其中30例注射纳米碳为试验组,37例未用纳米碳为对照组。比较两组患者术后甲状旁腺功能的变化情况。结... 目的探讨纳米碳在甲状腺癌手术中对甲状旁腺的保护作用。方法回顾性分析2014年1月至2015年1月我院收治的67例甲状腺癌患者的临床资料,其中30例注射纳米碳为试验组,37例未用纳米碳为对照组。比较两组患者术后甲状旁腺功能的变化情况。结果两组患者年龄、性别、手术方式、术后病理等资料比较差异无统计学意义(P>0.05)。甲状旁腺损伤率(暂时性:试验组为3.33%,对照组为13.51%;永久性:试验组为0,对照组为8.11%)比较,试验组明显优于对照组(P<0.05)。结论甲状腺癌手术中应用纳米碳可以更好地保护甲状旁腺,降低甲状旁腺的损伤几率。 展开更多
关键词 甲状腺癌 纳米碳 甲状旁腺
下载PDF
上一页 1 2 10 下一页 到第
使用帮助 返回顶部